AILBRY - Article Search
Serach over 250 million academic articles from all areas of study
Results for 'Alogliptin'
:
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
Publication Year: 2013
DOI: https://doi.org/10.1056/nejmoa1305889
Abstract:
Add to Library
Authors:
William B. White
Christopher P. Cannon
Simon Heller
Steven E. Nissen
Gen Takagi
George L. Bakris
Alfonso T. Perez
Penny Fleck
Cyrus R. Mehta
Stuart Kupfer
Craig Wilson
William C. Cushman
Faı̈ez Zannad
Discovery of Alogliptin: A Potent, Selective, Bioavailable, and Efficacious Inhibitor of Dipeptidyl Peptidase IV
Publication Year: 2007
DOI: https://doi.org/10.1021/jm070104l
Abstract:
Add to Library
Authors:
Jun Feng
Zhiyuan Zhang
Michael B. Wallace
Jeffrey A. Stafford
Stephen W. Kaldor
Daniel B. Kassel
Marc Navre
Lihong Shi
R.J. Skene
Takeshi Asakawa
Koji Takeuchi
Rongda Xu
David R. Webb
Stephen L. Gwaltney
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
Publication Year: 2015
DOI: https://doi.org/10.1016/s0140-6736(14)62225-x
Abstract:
Add to Library
Authors:
Faı̈ez Zannad
Christopher P. Cannon
William C. Cushman
George L. Bakris
Venu Menon
Alfonso T. Perez
Penny Fleck
Cyrus R. Mehta
Stuart Kupfer
Craig Wilson
Hung‐Ming Lam
William B. White
Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Patients With Type 2 Diabetes and Inadequate Glycemic Control
Publication Year: 2008
DOI: https://doi.org/10.2337/dc08-1035
Abstract:
Add to Library
Authors:
Ralph A. DeFronzo
Penny Fleck
Craig Wilson
Qais Mekki
Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy
Publication Year: 2008
DOI: https://doi.org/10.1111/j.1463-1326.2008.01016.x
Abstract:
Add to Library
Authors:
Richard E. Pratley
Mark Kipnes
Penny Fleck
Candy Wilson
Qais Mekki
DPP-4 (CD26) Inhibitor Alogliptin Inhibits Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice
Publication Year: 2011
DOI: https://doi.org/10.1097/fjc.0b013e31821e5626
Abstract:
Add to Library
Authors:
Nga Ta
Corinne A. Schuyler
Yanchun Li
Maria F. Lopes‐Virella
Yan Huang
Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA<sub>1c</sub> without causing weight gain or increased hypoglycaemia
Publication Year: 2009
DOI: https://doi.org/10.1111/j.1463-1326.2009.01124.x
Abstract:
Add to Library
Authors:
Julio Rosenstock
Marc Rendell
Jorge Luiz Gross
Penny Fleck
Carol Wilson
Qais Mekki
Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)
Publication Year: 2015
DOI: https://doi.org/10.2337/dc15-0781
Abstract:
Add to Library
Authors:
Tomoya Mita
Naoto Katakami
Hidenori Yoshii
Tomio Onuma
Hideaki Kaneto
Takeshi Osonoi
Toshihiko Shiraiwa
Keisuke Kosugi
Yutaka Umayahara
Tsunehiko Yamamoto
Hiroki Yokoyama
Nobuichi Kuribayashi
Hideaki Jinnouchi
Masahiko Gosho
Iichiro Shimomura
Hirotaka Watada
Cardiovascular safety of the dipetidyl peptidase‐4 inhibitor alogliptin in type 2 diabetes mellitus
Publication Year: 2013
DOI: https://doi.org/10.1111/dom.12093
Abstract:
Add to Library
Authors:
William B. White
Richard E. Pratley
Penny Fleck
Melvin Munsaka
Michie Hisada
Candy Wilson
Venu Menon
Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study
Publication Year: 2009
DOI: https://doi.org/10.1111/j.1742-1241.2008.01933.x
Abstract:
Add to Library
Authors:
Michael A. Nauck
Graham Ellis
Penny Fleck
Carol Wilson
Qais Mekki
Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naïve Patients With Type 2 Diabetes
Publication Year: 2010
DOI: https://doi.org/10.2337/dc10-0159
Abstract:
Add to Library
Authors:
Julio Rosenstock
Silvio E. Inzucchi
Jochen Seufert
Penny Fleck
Craig Wilson
Qais Mekki
EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome (EXAMINE)
Publication Year: 2011
DOI: https://doi.org/10.1016/j.ahj.2011.08.004
Abstract:
Add to Library
Authors:
William B. White
George L. Bakris
Gen Takagi
Christopher P. Cannon
William C. Cushman
Penny Fleck
Simon Heller
Cyrus R. Mehta
Steven E. Nissen
Alfonso Pérez
Craig Wilson
Faı̈ez Zannad
Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects
Publication Year: 2008
DOI: https://doi.org/10.1016/j.clinthera.2008.03.005
Abstract:
Add to Library
Authors:
Ronald J. Christopher
Paul S. Covington
Miles P. Davenport
Penny Fleck
Qais Mekki
Elisabeth R. Wann
Aziz Karim
Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study
Publication Year: 2008
DOI: https://doi.org/10.1111/j.1742-1241.2008.01933.x
Abstract:
Add to Library
Authors:
Michael A. Nauck
Graham Ellis
Penny Fleck
Carol Wilson
Qais Mekki
Alogliptin
Publication Year: 2010
DOI: https://doi.org/10.2165/11205080-000000000-00000
Abstract:
Add to Library
Authors:
Found 5013 results in 0.06 seconds
What is Boolean Searches
Including any of the words AND
, OR
, or NOT
in any of your searches will enable
boolean search. Those words must be UPPERCASE . You can use this in all searches, including using
the search parameter, and using search filters.
This allows you to craft complex queries using those boolean operators along with parentheses and quotation marks.
Surrounding a phrase with quotation marks will search for an exact match of that phrase, after stemming and
stop-word removal (be sure to use double quotation marks — "
). Using parentheses will specify order of
operations for the boolean operators. Words that are not separated by one of the boolean operators will be
interpreted as AND
.
Behind the scenes, the boolean search is using Elasticsearch's query string query on the searchable fields (such as
title, abstract, and fulltext for works; see each individual entity page for specifics about that entity). Wildcard
and fuzzy searches using *
, ?
or ~
are not allowed; these characters will be
removed from any searches. These searches, even when using quotation marks, will go through the same cleaning as
described above, including stemming and removal of stop words.
Example Search
Search for works that mention "elmo"
and "sesame street"
, but not the words
"cookie"
or "monster"
:
"elmo" AND "sesame street" NOT "cookie" NOT "monster"